Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

76.9K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
76.9K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K
DNA Bacteriophages01:26

DNA Bacteriophages

576
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
576
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

67.0K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

912
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
912
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

1.1K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetics and transgenerational inheritance.

The Journal of physiology·2023
Same author

Phage Therapy in Germany-Update 2023.

Viruses·2023
Same author

The Roles of the Virome in Cancer.

Microorganisms·2021
Same author

Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source.

Viruses·2021
Same author

Viroids and the Origin of Life.

International journal of molecular sciences·2021
Same author

Half a century of the reverse transcriptase-happy birthday!

Genome biology·2021

Related Experiment Video

Updated: Dec 14, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.3K

Phages Needed against Resistant Bacteria.

Karin Moelling1,2

  • 1Institute for Medical Microbiology, University Zurich, Gloriastr 30, CH-8006 Zurich, Switzerland.

Viruses
|July 16, 2020
PubMed
Summary

Bacteriophages (phages) show promise as therapies against antibiotic-resistant infections. Current regulations hinder phage production, requiring urgent updates for clinical integration.

Keywords:
case reportsmultidrug-resistant bacteriaphage therapyprobioticsregulation

More Related Videos

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.4K
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.0K

Related Experiment Videos

Last Updated: Dec 14, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.3K
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.4K
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.0K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Bacteriophages (phages) have a century-long history of therapeutic application against infectious diseases.
  • Phage therapy was largely overshadowed by the advent of antibiotics but is regaining interest due to rising antimicrobial resistance.
  • Existing international regulations are inadequate for the Good Manufacturing Practice (GMP) production of phages.

Purpose of the Study:

  • To evaluate the potential of phages as an alternative therapy for infectious diseases.
  • To highlight regulatory challenges in phage production and clinical translation.
  • To advocate for regulatory reform to facilitate phage therapy's integration into clinical practice.

Main Methods:

  • Review of historical phage therapy applications.
  • Analysis of current international regulatory frameworks for biologicals.
  • Assessment of Good Manufacturing Practice (GMP) standards in relation to phage characteristics.

Main Results:

  • Phages have demonstrated efficacy in numerous infectious disease cases.
  • Current GMP regulations, designed for chemical compounds, are unsuitable for biological phage production.
  • A significant regulatory gap exists for phage-based therapeutics.

Conclusions:

  • Phage therapy presents a viable option to combat antibiotic-resistant microorganisms.
  • Urgent revision of GMP regulations is necessary to accommodate phage production.
  • Regulatory adaptation is crucial for advancing phage therapy into routine clinical settings.